GENE ONLINE|News &
Opinion
Blog

2019-11-05| China

2019 CSCO China, with highlights on proteomics-driven precision medicine, oncology treatment and quality control, and breakthroughs in drug developments

by GeneOnline
Share To
The 22nd annual installment of the Chinese Society of Clinical Oncology (CSCO) meeting, took place at the Xiamen International Conference Center on September 19, for 4 days. The theme of the 22nd conference was “Precision & Intelligence: Hope to conquer cancer”. The conference had four aims: (1) Encourage the exchange of new knowledge and technology in clinical oncology; (2) Promote scientific exchange between China and other countries; (3) Support academic research; (4) Support innovation in the industry. The conference attracted approximately 30,000 participants, more than 600 speakers and paper presenters from China and abroad, and 275 manufacturers from China. Geneonline attended the CSCO meeting, and reported the highlights of this conference.

GO Prime with only $1.49 now

LATEST
GSK Bets $593 Million To License Scynexis’ Oral Antifungal
2023-03-31
3D Printed Brain Model Could Aid in Neurosurgery
2023-03-31
Latest Study on Neuronal Gene Expression May Shed Light on the Memory Formation Process
2023-03-30
Emergent BioSolutions’ Over-The-Counter Naloxone Nasal Spray Receives FDA Greenlight
2023-03-30
Current Trends of iPSC Manufacturing and Clinical Applications – An Interview with Professor Xianmin Zeng
2023-03-29
U.S.-German Joint Discovery May Spark Breakthrough in Diabetes Research
2023-03-29
Merck Regains Worldwide Rights to BAVENCIO After Parting Ways with Pfizer
2023-03-29
Scroll to Top